Facilitated By

San Antonio Medical Foundation

A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study To Assess Efficacy And Safety Of SER-287 In Adults With Active Mild-To-Moderate Ulcerative Colitis

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Research Start Date
Status
Active

The primary objective of this study is to demonstrate the efficacy of SER-287, after ten (10) weeks of induction dosing (following vancomycin pre-treatment), in achieving clinical remission.

Collaborative Project
Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.